Skip to content
Commercial Litigation Woods Lonergan LLP

212.684.2500

Copyright Litigation

Nutritional High Expands FLI Brand to Washington State - GlobeNewswire (press release)

October 30, 2017 - 7:57am

Nutritional High Expands FLI Brand to Washington State
GlobeNewswire (press release)
Nutritional High and Mt. Baker Greeneries have also entered into agreements whereby Nutritional High will sublease the facility to Mt. Baker Greeneries and provide its intellectual property, including recipes, branding, packaging, and other know-how to Mt.

and more »

Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase 1b Study of OXi4503 in Acute Myeloid ... - GlobeNewswire (press release)

October 30, 2017 - 7:46am

Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase 1b Study of OXi4503 in Acute Myeloid ...
GlobeNewswire (press release)
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today announced updated ...

and more »

XpresSpa Opens First Location in Terminal 8 of New York's John F. Kennedy International Airport - GlobeNewswire (press release)

October 30, 2017 - 7:31am

GlobeNewswire (press release)

XpresSpa Opens First Location in Terminal 8 of New York's John F. Kennedy International Airport
GlobeNewswire (press release)
FORM's current holdings include XpresSpa, Group Mobile, Infomedia and intellectual property assets. XpresSpa is the world's largest airport spa company. Group Mobile is a provider of rugged, mobile and field-use computing products, serving customers ...

and more »

Sauer Energy WindCutter on Display - GlobeNewswire (press release)

October 30, 2017 - 6:55am

GlobeNewswire (press release)

Sauer Energy WindCutter on Display
GlobeNewswire (press release)
Factors that may cause actual results to differ include without limitation: dependence on key personnel and suppliers; SEI's ability to commercialize its wind turbine technology; ability to defend intellectual property; wind turbine material and ...

and more »

Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility ... - GlobeNewswire (press release)

October 30, 2017 - 6:30am

Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility ...
GlobeNewswire (press release)
NEW YORK, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech, Inc. (NASDAQ:FBIO) company focused ...

and more »

Crescendo Bioscience Announces Six Presentations at the ... - GlobeNewswire (press release)

October 30, 2017 - 6:05am

Crescendo Bioscience Announces Six Presentations at the ...
GlobeNewswire (press release)
SALT LAKE CITY, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today ...

and more »

BioCanCell Announces Exploration of Funding Round Conditioned on a Going Private Transaction and Business ... - GlobeNewswire (press release)

October 30, 2017 - 6:02am

BioCanCell Announces Exploration of Funding Round Conditioned on a Going Private Transaction and Business ...
GlobeNewswire (press release)
... an ability to overcome scientific or technological difficulties that may be encountered and that may impede R&D activities; and an ability to obtain and maintain intellectual property protection for product candidates, including pursuant to ...

and more »

Aviragen Therapeutics and Vaxart Enter into Merger Agreement - GlobeNewswire (press release)

October 30, 2017 - 6:02am

Aviragen Therapeutics and Vaxart Enter into Merger Agreement
GlobeNewswire (press release)
... Aviragen or Vaxart to protect their respective intellectual property rights; competitive responses to the merger; unexpected costs, charges or expenses resulting from the merger; and potential adverse reactions or changes to business relationships ...

and more »

Novartis to present first of its kind evidence for Cosentyx® on ... - GlobeNewswire (press release)

October 30, 2017 - 1:16am

Novartis to present first of its kind evidence for Cosentyx® on ...
GlobeNewswire (press release)
Basel, October 30, 2017 - New evidence on the efficacy of the innovative biologic Cosentyx® (secukinumab) demonstrating its potential to reduce structural ...

and more »

Novartis announces the planned acquisition of Advanced ... - GlobeNewswire (press release)

October 30, 2017 - 1:01am

Novartis announces the planned acquisition of Advanced ...
GlobeNewswire (press release)
Basel, October 30, 2017 - Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under ...

and more »